Author Correction: Identification and mechanism of action of a novel small-molecule inhibitor of arenavirus multiplication [J Virol, 89, 21, (2015) (10924-10933)] DOI: 10.1128/JVI.01587-15;Identification and mechanism of action of a novel small-molecule inhibitor of arenavirus multiplication

Journal of Virology

Volumn 89, Issue 21, 2015, Pages 10924-10933

  Ngo, Nhi ^a   Cubitt, Beatrice ^a   Iwasaki, Masaharu ^a   de la Torre, Juan C ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GP2 PROTEIN; N [3,5 BIS(FLUORANYL)PHENYL] 2 [5,7 BIS(OXIDANYLIDENE) 6 PROPYL 2 PYRROLIDIN 1 YL[1,3]THIAZOLO[4,5 D]PYRIMIDIN 4 YL]ETHANAMIDE; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; F3406-2010; MOLECULAR LIBRARY; PYRIMIDINONE DERIVATIVE; THIAZOLE DERIVATIVE;

AMINO ACID SEQUENCE; ANTIVIRAL SUSCEPTIBILITY; ARENAVIRUS; ARTICLE; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG STRUCTURE; ENDOSOME; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS ENTRY; VIRUS GENOME; VIRUS INHIBITION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TRANSCRIPTION; ANIMAL; ARENAVIRIDAE INFECTIONS; CHEMISTRY; CHLOROCEBUS AETHIOPS; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; HIGH THROUGHPUT SCREENING; HUMAN; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOLECULAR LIBRARY; PHYSIOLOGY; PLASMID; VERO CELL LINE; WESTERN BLOTTING;

ANIMALS; ARENAVIRIDAE INFECTIONS; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; HEK293 CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PLASMIDS; PYRIMIDINONES; SMALL MOLECULE LIBRARIES; THIAZOLES; VERO CELLS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84945205382     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01289-16     Document Type: Erratum

References (46)

1. Buchmeier MJ, Peters CJ, de la Torre JC. 2007. Arenaviridae: the viruses and their replication, p 1791-1851. In Knipe DM, Holey PM (ed), Fields virology, 5th ed, vol 2. Lippincott/The Williams & Wilkins Co, Philadelphia, PA.
2. Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, Nichol ST, Compans RW, Campbell KP, Oldstone MB. 1998. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282:2079-2081. http://dx.doi.org/10.1126 /science.282.5396.2079.
3. York J, Romanowski V, Lu M, Nunberg JH. 2004. The signal peptide of the Junin arenavirus envelope glycoprotein is myristoylated and forms an essential subunit of the mature G1-G2 complex. J Virol 78:10783-10792. http://dx.doi.org/10.1128/JVI.78.19.10783-10792.2004.
4. Enria DA, Briggiler AM, Sanchez Z. 2008. Treatment of Argentine hemorrhagic fever. Antivir Res 78:132-139. http://dx.doi.org/10.1016/j .antiviral.2007.10.010.
5. Geisbert TW, Jahrling PB. 2004. Exotic emerging viral diseases: progress and challenges. Nat Med 10:S110 -S121. http://dx.doi.org/10.1038 /nm1142.
6. Khan SH, Goba A, Chu M, Roth C, Healing T, Marx A, Fair J, Guttieri MC, Ferro P, Imes T, Monagin C, Garry RF, Bausch DG, Mano River Union Lassa Fever N. 2008. New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antivir Res 78:103-115. http: //dx.doi.org/10.1016/j.antiviral.2007.11.003.
7. McCormick JB, Fisher-Hock SP. 2002. Lassa fever. Curr Top Microbiol Immunol 262:75-109.
8. Peters CJ. 2002. Human infection with arenaviruses in the Americas. Curr Top Microbiol Immunol 262:65-74.
9. Barton LL, Mets MB. 1999. Lymphocytic choriomeningitis virus: pediatric pathogen and fetal teratogen. Pediatr Infect Dis J 18:540-541. http: //dx.doi.org/10.1097/00006454-199906000-00013.
10. Barton LL, Mets MB. 2001. Congenital lymphocytic choriomeningitis virus infection: decade of rediscovery. Clin Infect Dis 33:370-374. http: //dx.doi.org/10.1086/321897.
11. Barton LL, Mets MB, Beauchamp CL. 2002. Lymphocytic choriomeningitis virus: emerging fetal teratogen. Am J Obstet Gynecol 187:1715-1716. http://dx.doi.org/10.1067/mob.2002.126297.
12. Jahrling PB, Peters CJ. 1992. Lymphocytic choriomeningitis virus: a neglected pathogen of man. Arch Pathol Lab Med 116:486-488.
13. Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM, Jahrling PB, Ksiazek T, Johnson KM, Meyerhoff A, O'Toole T, Ascher MS, Bartlett J, Breman JG, Eitzen EM, Jr, Hamburg M, Hauer J, Henderson DA, Johnson RT, Kwik G, Layton M, Lillibridge S, Nabel GJ, Osterholm MT, Perl TM, Russell P, Tonat K, Working Group on Civilian Biodefense.Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 287:2391-2405. http://dx.doi.org/10 .1001/jama.287.18.2391.
14. Damonte EB, Coto CE. 2002. Treatment of arenavirus infections: from basic studies to the challenge of antiviral therapy. Adv Virus Res 58:125-155. http://dx.doi.org/10.1016/S0065-3527(02)58004-0.
15. Moreno H, Gallego I, Sevilla N, de la Torre JC, Domingo E, Martin V. Ribavirin can be mutagenic for arenaviruses. J Virol 85:7246-7255. http://dx.doi.org/10.1128/J.V.I.00614-11.
16. Parker WB. 2005. Metabolism and antiviral activity of ribavirin. Virus Res 107:165-171. http://dx.doi.org/10.1016/j.virusres.2004.11.006.
17. Sanchez AB, de la Torre JC. 2006. Rescue of the prototypic arenavirus LCMVentirely from plasmid. Virology 350:370-380. http://dx.doi.org/10 .1016/j.virol.2006.01.012.
18. Yun NE, Seregin AV, Walker DH, Popov VL, Walker AG, Smith JN, Miller M, de la Torre JC, Smith JK, Borisevich V, Fair JN, Wauquier N, Grant DS, Bockarie B, Bente D, Paessler S. 2013. Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus. J Virol 87:10908-10911. http://dx.doi.org/10.1128/JVI.01433-13.
19. Emonet SF, Seregin AV, Yun NE, Poussard AL, Walker AG, de la Torre JC, Paessler S. 2011. Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and liveattenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease. J Virol 85:1473-1483. http://dx .doi.org/10.1128/JVI.02102-10.
20. Emonet SE, Urata S, de la Torre JC. 2011. Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies. Virology 411:416-425. http://dx.doi.org/10 .1016/j.virol.2011.01.013.
21. Emonet SF, Garidou L, McGavern DB, de la Torre JC. 2009. Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc Natl Acad Sci U S A 106:3473-3478. http://dx.doi.org/10.1073/pnas.0900088106.
22. Lee KJ, Perez M, Pinschewer DD, de la Torre JC. 2002. Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J Virol 76:6393-6397. http://dx.doi.org/10.1128/JVI.76.12.6393-6397.2002.
23. Pinschewer DD, Perez M, Sanchez AB, de la Torre JC. 2003. Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. Proc Natl Acad Sci U S A 100:7895-7900. http://dx.doi .org/10.1073/pnas.1332709100.
24. Rojek JM, Sanchez AB, Nguyen NT, de la Torre JC, Kunz S. 2008. Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J Virol 82:7677-7687. http://dx.doi.org/10.1128 /JVI.00560-08.
25. Urata S, Ngo N, de la Torre JC. 2012. The PI3K/Akt pathway contributes to arenavirus budding. J Virol 86:4578-4585. http://dx.doi.org/10.1128 /JVI.06604-11.
26. Vazquez-Calvo A, Martin-Acebes MA, Saiz JC, Ngo N, Sobrino F, de la Torre JC. 2013. Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid. Antivir Res 99:172-179. http://dx.doi.org/10 .1016/j.antiviral.2013.05.012.
27. Szymczak-Workman AL, Vignali KM, Vignali DA. 2012. Design and construction of 2A peptide-linked multicistronic vectors. Cold Spring Harb Protoc 2012:199-204. http://dx.doi.org/10.1101/pdb.ip067876.
28. Rojek JM, Perez M, Kunz S. 2008. Cellular entry of lymphocytic choriomeningitis virus. J Virol 82:1505-1517. http://dx.doi.org/10.1128/JVI.01331-07.
29. Lee KJ, Novella IS, Teng MN, Oldstone MB, de La Torre JC. 2000. NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J Virol 74:3470-3477. http://dx.doi.org/10.1128/JVI.74.8.3470-3477.2000.
30. Urata S, Yasuda J, de la Torre JC. 2009. The z protein of the new world arenavirus tacaribe virus has bona fide budding activity that does not depend on known late domain motifs. J Virol 83:12651-12655. http://dx .doi.org/10.1128/JVI.01012-09.
31. Battegay M, Cooper S, Althage A, Banziger J, Hengartner H, Zinkernagel RM. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24-or 96-well plates. J Virol Methods 33:191-198. http://dx.doi.org/10.1016/0166-0934(91)90018-U.
32. Perez M, Craven RC, de la Torre JC. 2003. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A 100:12978-12983. http://dx.doi.org/10.1073 /pnas.2133782100.
33. Borrow P, Oldstone MB. 1994. Mechanism of lymphocytic choriomeningitis virus entry into cells. Virology 198:1-9. http://dx.doi.org/10.1006 /viro.1994.1001.
34. Castilla V, Mersich SE, Candurra NA, Damonte EB. 1994. The entry of Junin virus into Vero cells. Arch Virol 136:363-374. http://dx.doi.org/10 .1007/BF01321064.
35. Radoshitzky SR, Abraham J, Spiropoulou CF, Kuhn JH, Nguyen D, Li W, Nagel J, Schmidt PJ, Nunberg JH, Andrews NC, Farzan M, Choe H. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446:92-96. http://dx.doi.org/10.1038 /nature05539.
36. Eschli B, Quirin K, Wepf A, Weber J, Zinkernagel R, Hengartner H. Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteins. J Virol 80:5897-5907. http://dx.doi.org/10.1128/JVI.00008-06.
37. Igonet S, Vaney MC, Vonrhein C, Bricogne G, Stura EA, Hengartner H, Eschli B, Rey FA. 2011. X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation. Proc Natl Acad Sci U S A 108:19967-19972. http://dx.doi.org/10.1073/pnas.1108910108.
38. Shah NR, Sunderland A, Grdzelishvili VZ. 2010. Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin. PLoS One 5:e11265. http://dx.doi.org/10.1371/journal.pone.0011265.
39. York J, Dai D, Amberg SM, Nunberg JH. 2008. pH-induced activation of arenavirus membrane fusion is antagonized by small-molecule inhibitors. J Virol 82:10932-10939. http://dx.doi.org/10.1128/JVI.01140-08.
40. York J, Nunberg JH. 2006. Role of the stable signal peptide of Junin arenavirus envelope glycoprotein in pH-dependent membrane fusion. J Virol 80:7775-7780. http://dx.doi.org/10.1128/JVI.00642-06.
41. York J, Nunberg JH. 2009. Intersubunit interactions modulate pHinduced activation of membrane fusion by the Junin virus envelope glycoprotein GPC. J Virol 83:4121-4126. http://dx.doi.org/10.1128 /JVI.02410-08.
42. Bolken TC, Laquerre S, Zhang Y, Bailey TR, Pevear DC, Kickner SS, Sperzel LE, Jones KF, Warren TK, Amanda Lund S, Kirkwood-Watts DL, King DS, Shurtleff AC, Guttieri MC, Deng Y, Bleam M, Hruby DE. Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses. Antivir Res 69:86-97. http://dx.doi.org/10.1016/j.antiviral.2005.10.008.
43. Larson RA, Dai D, Hosack VT, Tan Y, Bolken TC, Hruby DE, Amberg SM. 2008. Identification of a broad-spectrum arenavirus entry inhibitor. J Virol 82:10768-10775. http://dx.doi.org/10.1128/JVI.00941-08.
44. Lee AM, Rojek JM, Spiropoulou CF, Gundersen AT, Jin W, Shaginian A, York J, Nunberg JH, Boger DL, Oldstone MB, Kunz S. 2008. Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses. J Biol Chem 283:18734 -18742. http://dx.doi.org/10.1074/jbc .M802089200.
45. Rathbun JY, Droniou ME, Damoiseaux R, Haworth KG, Henley JE, Exline CM, Choe H, Cannon PM. 2015. Novel arenavirus entry inhibitors discovered by using a minigenome rescue system for high-throughput drug screening. J Virol 89:8428-8443. http://dx.doi.org/10.1128/JVI .00997-15.
46. Iwasaki M, Urata S, Cho Y, Ngo N, de la Torre JC. 2014. Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes. Virology 458-459:22-32. http://dx.doi.org/10.1016/j.virol.2014.04.013.